AzTrials
AzTrials

Coronary DiseaseNCT04171570

DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention

A study testing Coronary angiography and or Percutaneous coronary Intervention in people with Coronary Disease, run by Terumo Europe N.V. at 16 sites in 10 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to demonstrate the superiority of Distal Radial Access (DTRA) to Conventional Transradial Access (CTRA) regarding forearm radial artery occlusion (RAO). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Disease
What is being tested?
Coronary angiography and or Percutaneous coronary Intervention
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,309 participants
Where
16 sitesin 10 countries
Study dates
10 Dec 2019to 28 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient is at least 18 years of age.
  • Patient has provided written informed consent.
  • Patient is undergoing diagnostic coronary angiography and/or PCI.
  • Patient is willing to comply with all protocol-required evaluations during the hospitalization.
  • Patient is suitable for both DTRA and CTRA using 6Fr GSS.

Who cannot join

  • Patient has a medical condition that may cause non-compliance with the protocol and/or confound the data interpretation.
  • Patients on chronic hemodialysis.
  • Patients presenting with ST-elevated myocardial infarction (STEMI).
  • Patients have chronic total occlusion (CTO) lesions in coronary artery.

Trial locations and contacts

16 sites in 10 countries.

16 sites in 10 countries

Belgium4 sites
  • UZ Brussel

    Brussels, 1090

  • Hôpital Civil Marie Curie

    Charleroi, Hainaut, 6042

  • CHU Jolimont

    Haine-Saint-Paul, Hainaut, 7100

  • Cliniques Universitaires Saint-Luc

    Woluwe-Saint-Lambert, Brussels Capital, 1200

Other trials in Belgium

Italy2 sites
  • Sant'Eugenio Hospital

    Roma, 00144

  • Istituto Clinico Humanitas

    Rozzano, 20089

Other trials in Italy

Switzerland2 sites
  • HUG Geneva

    Geneva, 1211

  • Kantonsspital Baselland Liestal

    Liestal, CH-4410

Other trials in Switzerland

United Kingdom2 sites
  • Royal Stoke University Hospital

    Stoke-on-Trent, ST4 6QG

  • Sunderland Royal Hospital

    Sunderland

Other trials in United Kingdom

Czechia1 site
  • Plzen Medical University

    Pilsen, 306 05

Other trials in Czechia

Germany1 site
  • University Hospital Johannes Wesling Klinikum Minden

    Minden, 32429

Other trials in Germany

Hungary1 site
  • Bács-Kiskun Megyei Kórház

    Kecskemét, 6000

Other trials in Hungary

Japan1 site
  • Shonan Kamakura General Hospital

    Kanagawa, 247-8533

Other trials in Japan

Netherlands1 site
  • Isala Hospital

    Zwolle, 8025 AB

Other trials in Netherlands

North Macedonia1 site
  • University Clinic of Cardiology, Skopje

    Skopje, 1000

Other trials in North Macedonia

About this study

Official title: DISCO Radial Trial: DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention: a Randomized Multicenter Trial

The objective of this study is to demonstrate the superiority of Distal Radial Access (DTRA) to Conventional Transradial Access (CTRA) regarding forearm radial artery occlusion (RAO).

This trial plans to include 1300 patients in around 12 locations around the world (11 participating sites in Europe and 1 participating site in Japan).

Read the detailed description

DISCO RADIAL is a prospective, global, open label, multi-centre randomized controlled trial with plan to include approximately 1300 patients on who transradial coronary angiography and/or intervention is performed. The patients will be randomized in 1:1 ratio to either Distal Transradial Artery Access (DTRA) or Conventional Transradial Access (CTRA) arm. In both arms 6Fr Glidesheath Slender (GSS) will be used as access sheath.

The sponsor will work in accordance with standard operating procedures (SOP) and the Monitoring Plan in order to ensure adherence to the CIP and applicable regulations at the investigational sites.

The Monitoring Plan is built according to a risk-based monitoring approach and describes the level of source data verification to be performed by the monitors.

Risk-based monitoring approach uses all available means to supervise the trial (central monitoring, remote monitoring and on-site monitoring), focusing in critical data points and issues ensuring that adequate monitoring (central, remote and on-site) at each site is completed to ensure protection of the rights and safety of the subjects and the quality and integrity of the data collected and submitted.

The sponsor shall provide training and the necessary guidelines to assist each investigational site on the data collection in the eCRF. Each site is responsible to report the available data requested by the CIP. In order to ensure data quality and avoid missing information in the eCRF, edit checks are designed during database development. In addition, Sponsor's CRA and Data Management team will be responsible to review the data and raise queries accordingly into the eCRF. An audit trail logging all data entered and edited is available within the EDC system. All source documents are maintained in the hospital files ready for inspection by the Sponsor and regulatory authorities upon request. The Sponsor will inform the investigator of the time period for retaining these records as per applicable regulatory requirements.

The following analysis sets will be considered for the statistical analysis :

As Treated Population This population includes all patients who were treated and undergo the studied procedure. Patients will be assigned to the study treatement groups according to the actual received treatement.

Intention-To-Treat Population This population includes all patients who have been randomized to a treatement. Patients will be assigned to the study treatement groups according to the treatement to which they have been randomized.

Per-Protocol Population This population includes all patients who were treated and undergo the studied procedure, excluding all patients with major violations to the protocol (e.g. wrong inclusion, missing data, mis-randomization, crossover, drop off before discharge). Patients will be assigned to the study treatement groups according to the treatement to which they have been randomized. All the protocol deviations will be reported in statistical report.

Assuming a rate of forearm RAO of 1% in DTRA and 3.5% in CTRA based on on two-sided alpha = 0.050 and power = 80%, 1:1 randomization needs 551 patients for each group to detect statistically significant differences in forearm RAO proportions. Then, given the crossover rate of 10% and the drop out rate of 5% for both group, at least 648 patients needs for each group to maintain proper statistical power. In total 1300 subjects will be randomized.

The primary endpoint analysis will be performed on ITT (Intention-To-Treat) population, by using two-sided superiority test with alpha = 0.05. Due to the short observation period (3 days ±2), a low number of missing data is expected. However, in case it exceeds 15-20%, missing, unused or spurious data will be considered using a tipping point analysis for each population. The comparaison in RAO rates between treatment groups will be tested by Chi-squared tests or Fisher's exact test, as appropriate. Odd-Ratio with IC95% will be calculated. Logistic regression analyses will be used to test the tendency.

Being tested
Coronary angiography and or Percutaneous coronary Intervention
Keywords
Distal Transradial Access, Randomized Multicenter Trial, Radial Access
Medical subject headings
Coronary Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coronary angiography and or Percutaneous coronary InterventionProcedure or surgery

    Radial access punture site

Study groups in NCT04171570
Study groupRoleWhat they receive
Distal Transradial AccessOtherDistal Transradial Access
Receives: Procedure: Coronary angiography and or Percutaneous coronary Intervention
Conventional Transradial AccessOtherConventional Transradial Access
Receives: Procedure: Coronary angiography and or Percutaneous coronary Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forearm radial artery occlusion (RAO) rate before discharge

    Forearm radial artery occlusion (RAO) rate before discharge measured with Doopler Ultrasound

    Measured: up to 5 days

Secondary outcomes (12)
  1. Rate of successful sheath insertion

    Rate of successful sheath insertion obtained though eCRF question

    Measured: up to 2 days

  2. Rate of access site crossover

    Rate of access site crossover - if the initial access point fails physician can perform the procedure using other access site of his/her choice This data point is captured on the eCRF

    Measured: up to 2 days

  3. Total procedural time

    Total procedural time defined as the time between initiation of local anesthesia to sheath removal - information captured on the eCRF

    Measured: up to 2 days

  4. Sheath insertion time

    Sheath insertion time recorded in the eCRF and defined as when puncture with the introducer needle first attempted until the time when introducer sheath is successfully inserted

    Measured: up to 2 days

  5. Puncture site bleeding according to EASY criteria

    Puncture site bleeding according to EASY criteria

    Measured: up to 5 days

  6. Overall bleeding according to BARC criteria

    Overall bleeding according to BARC criteria

    Measured: up to 5 days

  7. Vascular access-site complication

    Vascular access-site complication documented on the eCRF. It is composed by the rate of vessel perforation after occlusion requiring intervention, arterial dissection, pseudoaneurysm, and local haematoma

    Measured: up to 5 days

  8. Rate of radial artery spasm

    Rate of radial artery spasm captured in the eCRF. Radial arety spasm is defined as an inability to manipulate the guidewire or catheter in a smooth and pain-free manner and also as an inability to remove the sheath in a similar way at the end of the procedure

    Measured: up to 2 days

  9. Rate of distal radial artery occlusion (dRAO)

    Rate of distal radial artery occlusion (dRAO) by doopler ultrasound and capture in the eCRF

    Measured: up to 5 days

  10. Patent hemostasis was achieved or not (CTRA) by reverse barbeau test

    Patent hemostasis was achieved or not (CTRA) by reverse barbeau test

    Measured: up to 5 days

  11. Time required to reach hemostasis

    Time required to reach hemostasis, captured on the eCRF and defined as the time between sheath removal to complete hemostasis

    Measured: up to 5 days

  12. Pain associated with the procedure: Visual Assessment Scale (VAS)

    Pain associated with the procedure measured by the Visual Assessment Scale (VAS), a numeric rating scale. VAS is a 10 cm line with anchor statements on the left (no pain = 0) and on the right (worst possible pain = 10)

    Measured: up to 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2019
  2. Study start10 Dec 2019
  3. Primary completion28 Dec 2021
  4. Study completion28 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization to distal transradial access or conventional transradial access. Both techniques are standard of care.
Masking
None (open label)
Enrolment
1,309 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04171570
Sponsor's protocol ID
T133E3
Status last verified
May 2022
First submitted
23 Oct 2019
Last updated
24 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kiemeneij F. Left distal transradial access in the anatomical snuffbox for coronary angiography (ldTRA) and interventions (ldTRI). EuroIntervention. 2017 Sep 20;13(7):851-857. doi: 10.4244/EIJ-D-17-00079.

    PubMed 28506941
  • Corcos T. Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review. Catheter Cardiovasc Interv. 2019 Mar 1;93(4):639-644. doi: 10.1002/ccd.28016. Epub 2018 Dec 11.

    PubMed 30536709
  • Sgueglia GA, Di Giorgio A, Gaspardone A, Babunashvili A. Anatomic Basis and Physiological Rationale of Distal Radial Artery Access for Percutaneous Coronary and Endovascular Procedures. JACC Cardiovasc Interv. 2018 Oct 22;11(20):2113-2119. doi: 10.1016/j.jcin.2018.04.045.

    PubMed 30336816
  • Aminian A, Saito S, Takahashi A, Bernat I, Jobe RL, Kajiya T, Gilchrist IC, Louvard Y, Kiemeneij F, Van Royen N, Yamazaki S, Matsukage T, Rao SV. Comparison of a new slender 6 Fr sheath with a standard 5 Fr sheath for transradial coronary angiography and intervention: RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT), a randomised multicentre trial. EuroIntervention. 2017 Aug 4;13(5):e549-e556. doi: 10.4244/EIJ-D-16-00816.

    PubMed 28218605

Questions about this trial

What is this clinical trial studying?

A study testing Coronary angiography and or Percutaneous coronary Intervention in people with Coronary Disease, run by Terumo Europe N.V. at 16 sites in 10 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in Belgium, Italy, Switzerland, United Kingdom, Czechia and 5 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forearm radial artery occlusion (RAO) rate before discharge (time frame: up to 5 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04171570, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in